Most Popular Stories
- Lawsuits starting to mount against Goldman Sachs
- What to make of Goldman Sachs' move into derivatives clearing?
- Citigroup explores Volcker Rule options
- SEC seeks comments on fiduciary standard vs. suitability
- Goldman Sachs' hedges on AIG exposure debated
- Tabb Group: Buy-side continues to embrace algorithms
Events
Sponsored Links
FEATURES >> Where are they now? The whistleblowers edition | Q2 Earnings
TOPICS >> Hedge Funds | Derivatives Trading | Regulatory News | Top Banks: GS C BAC JPM WFC MS
Latest News
Free Newsletter
FierceFinance is the financial services daily monitor, with news covering the banking industry, asset management, capital markets and SEC regulations. Sign up today!
We never sell or give away your contact information. Our reader's trust comes first.
Goldman Sachs, JPMorgan require more collateral from funds
When the financial crisis started to clear, it was clear that the tolerance by many dealers to assume risk had fallen (credit crisis news). Into that void stepped Goldman Sachs (NYSE: GS), which willingly expanded its trading operations--much of it on an agency basis--and reaped the reward in the form of expanded spreads, higher commissions and less competition. It--along with JPMorgan --was also left as one of the more active dealers in over-the-counter derivatives markets.
Bloomberg notes that the two firms have reaped some big rewards. They are able to require hedge funds (hedge fund news) to post more collateral, while putting less collateral themselves. The result for Goldman Sachs, as of the end of December, was a $110 billion imbalance in its favor. You certainly can't blame anyone for wanting to extract more collateral from counterparties. That's prudent risk management.
In contrast, Bloomberg notes, Citigroup (NYSE: C) paid out $11 billion more in collateral on over-the-counter derivatives than it collected at the end of 2009. The issue here is whether the market will force collateral requirements any lower. In theory, other dealers could require less in collateral and thus win some business from Goldman Sachs. We'll just have to see. The reality may be that there are few firms with enough heft to be a massive market maker in OTC derivatives.
For more:
- here's the Bloomberg article
Related Articles:
Goldman Sachs in Manchester United flap
The role of Goldman Sachs in Greek crisis
JPMorgan bests Goldman Sachs in banking
Related Stories
- Citadel's Kenneth Griffin pitches funds in new environment
- New book offers another view of Goldman Sachs's destructive power
- Goldman Sachs, short-term winner or loser?
- Effects of regulation on hedge funds not onerous
- Update: State of the reform bill
- Volcker Rule goes down to the wire
- Big shake-up in the hedge fund universe
- Bank to tie hedge fund lending to their own CDSs
- JPMorgan's investment bank reveals big challenges
- Goldman Sachs treated too well by regulators in AIG mess?
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2010 FierceMarkets. All rights reserved. |
![]() |



